Joe Y Chang, Professor, Clinical Section Chief at MD Anderson Cancer Center, shared a post on X:
“I was called about my patient who was diagnosed with highly curable stage I adenocarcinoma in February 2023. We recommended SABR or surgery, but she declined standard care and pursued alternative plant-based treatment instead. Now, She developed diffuse brain metastasis.
SAD!”
